Fresenius Medical Care with clear analyst view, shares tracked on Xetra and NYSE
23.06.2026 - 20:43:42 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:40.
Fresenius Medical Care (DE0005785802) combines a Xetra blue-chip profile with an American Depositary Receipt on the NYSE under the ticker FMS. The shares attract a dense analyst coverage that sets earnings expectations and price targets for the coming quarters.
What consensus data show today
On analysis platforms, Fresenius Medical Care is often grouped with Fresenius SE and international dialysis providers when investors compare valuation and margins. One consensus snapshot compiled by MarketScreener cites a market capitalization in the high single-digit billion euro range for the German listing, reflecting its role in the European healthcare sector.
Analyst pages summarize that several houses keep a neutral to positive stance on the stock, with 12-month price targets that frame the expected earnings progress. As a reference point for US investors, quote services such as MarketBeat list the ADR around the mid-20 US dollar band in recent trading, including intraday changes.
How the ADR is viewed in the US
In New York, the Fresenius Medical Care ADR trades under the symbol FMS on the NYSE, giving US investors direct exposure to the dialysis specialist. Earnings calendars on MarketBeat and similar platforms highlight the next reporting dates and compile analyst EPS estimates for upcoming quarters.
These US-focused services often show a mix of ratings from international banks and local brokerages, including Buy, Hold and Sell recommendations. For retail investors, such overviews help to position Fresenius Medical Care against US-listed healthcare peers when deciding on portfolio weighting.
All news and analysis on the Fresenius Medical Care shares
Further figures, filings and commentary on Fresenius Medical Care can be found in the dedicated topic area and the company's investor-relations section.
How Fresenius Medical Care earns its money
Fresenius Medical Care focuses on chronic kidney failure, operating dialysis clinics worldwide and supplying dialysis machines and consumables. Revenue streams come from treatment services billed to healthcare payers and the sale of equipment like hemodialysis machines and dialyzers.
Where the shares trade today
The Fresenius Medical Care shares (DE0005785802) trade in Germany on Xetra under the ticker FME and as an ADR on the NYSE under FMS. As of 2026-06-23, 18:00, recent reference data put the US ADR around 23.68 US dollars and imply a market capitalization near 10 billion euros.
Key data on the Fresenius Medical Care shares
- Company: Fresenius Medical Care AG & Co. KGaA
- ISIN: DE0005785802
- WKN: 578580
- Ticker: FME (Xetra) / FMS (NYSE ADR)
- Trading venue: Xetra / NYSE
- Price (as of 2026-06-23, 18:00): 23.68 USD (ADR reference)
- Market cap: around 9.9 billion EUR (as of 2026-06-23)
- Sector / industry: Healthcare – dialysis services and medical technology
- Index membership: DAX
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial service.
